Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Non-Current Debt (2016 - 2025)

AtriCure (ATRC) has disclosed Non-Current Debt for 15 consecutive years, with $61.9 million as the latest value for Q4 2025.

  • Quarterly Non-Current Debt changed 0.0% to $61.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $61.9 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $61.9 million for FY2025, 0.0% changed from the prior year.
  • Non-Current Debt for Q4 2025 was $61.9 million at AtriCure, roughly flat from $61.9 million in the prior quarter.
  • The five-year high for Non-Current Debt was $61.9 million in Q1 2024, with the low at $42.2 million in Q3 2023.
  • Average Non-Current Debt over 5 years is $57.1 million, with a median of $60.0 million recorded in 2022.
  • The sharpest move saw Non-Current Debt decreased 29.82% in 2023, then surged 46.76% in 2024.
  • Over 5 years, Non-Current Debt stood at $59.7 million in 2021, then dropped by 4.87% to $56.8 million in 2022, then increased by 6.61% to $60.6 million in 2023, then grew by 2.1% to $61.9 million in 2024, then changed by 0.0% to $61.9 million in 2025.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $61.9 million, $61.9 million, and $61.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.